z-logo
Premium
Risk factors for post‐ ERCP pancreatitis and hyperamylasemia: A retrospective single‐center study
Author(s) -
He Qi Bin,
Xu Te,
Wang Jing,
Li Yun Hong,
Wang Lei,
Zou Xiao Ping
Publication year - 2015
Publication title -
journal of digestive diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.684
H-Index - 51
eISSN - 1751-2980
pISSN - 1751-2972
DOI - 10.1111/1751-2980.12258
Subject(s) - hyperamylasemia , medicine , endoscopic retrograde cholangiopancreatography , pancreatitis , single center , retrospective cohort study , pancreatic duct , univariate analysis , odds ratio , stent , surgery , general surgery , gastroenterology , multivariate analysis , biochemistry , chemistry , enzyme , amylase
Objective With an increased use of endoscopic retrograde cholangiopancreatography ( ERCP ), post‐ERCP complications have attracted much attention. We aimed to identify independent risk factors of post‐ ERCP pancreatitis ( PEP ) and hyperamylasemia, and to develop a simple scoring system of the factors contributing to the clinical prevention against PEP . Methods A retrospective single‐center analysis was performed in 4234 ERCP procedures between S eptember 2007 and D ecember 2012. Patient‐related and procedure‐related risk factors for PEP and post‐ERCP hyperamylasemia were identified by univariate and multivariate regression analyses. A scoring system was developed based on the independent risk factors. Results PEP occurred in 226 (5.3%) ERCP procedures and hyperamylasemia in 774 (18.3%) procedures. Female gender (odds ratio [ OR ] 1.449), first‐time ERCP ( OR 1.745), latent jaundice ( OR 1.917), difficult cannulation ( OR 3.317) and pancreatography ( OR 1.823) were all proven to be significant risk factors for predicting PEP . In addition, difficult cannulation ( OR 1.990) and pancreatography ( OR 2.009), age <60 years ( OR 1.294), prior diabetes ( OR 0.614), biliary duct stent placement ( OR 1.884) and nasobiliary drainage ( OR 1.613) were associated with developing hyperamylasemia. Prophylactic pancreatic duct stent ( PS ) might prevent against PEP in significantly high‐risk patients (score ≥6). Conclusions Both patient‐related and procedure‐related risk factors are important for predicting PEP and post‐ERCP hyperamylasemia. Technical procedures, for example, PS , are necessary to prevent PEP in patients at the highest risk.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom